Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects

Core Viewpoint - Royal Philips has successfully priced EUR 1 billion in fixed rate notes, with maturities in 2030 and 2035, to support corporate purposes and refinance existing debt [1][2]. Group 1: Financial Details - The offering consists of EUR 500 million notes due 2030 with a coupon of 3.250% and a yield of 3.281%, and EUR 500 million notes due 2035 with a coupon of 4.000% and a yield of 4.050% [2]. - The issue price for the 2030 notes is 99.859% and for the 2035 notes is 99.595% [2]. - The 5-year and 10-year tranches were oversubscribed by more than 3 times and 4 times, respectively [2]. Group 2: Settlement and Listing - Settlement and issue of the notes are scheduled for May 23, 2025 [3]. - Application has been made for the notes to be listed on the Official List of the Luxembourg Stock Exchange [3]. Group 3: Credit Ratings - Philips maintains a strong investment grade credit rating with a BBB+ rating from Standard & Poor's, a Baa1 rating from Moody's, and a BBB+ rating from Fitch, all with stable outlooks [3]. Group 4: Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation, generating EUR 18 billion in sales in 2024 and employing approximately 67,200 people [11].